Cuorips Income Statement

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024
Revenue	356	175	23
Revenue Growth (YoY)	947.06%	660.87%	-
Cost of Revenue	83	7	13
Gross Profit	273	168	10
Selling, General & Admin	734	423	388
Research & Development	334	334	209
Operating Expenses	1,069	758	598
Operating Income	-796	-590	-588
Interest & Investment Income	13	4	-
Currency Exchange Gain (Loss)	8	-36	-
Other Non Operating Income (Expenses)	-1	-18	-41
EBT Excluding Unusual Items	-776	-640	-629
Gain (Loss) on Sale of Investments	8	-1	1
Asset Writedown	-	-	-3
Other Unusual Items	-	-	1
Pretax Income	-768	-641	-630
Income Tax Expense	2	3	2
Net Income	-765	-644	-632
Net Income to Common	-765	-644	-632
Shares Outstanding (Basic)	8	8	7
Shares Outstanding (Diluted)	8	8	7
Shares Change (YoY)	2.40%	8.69%	-
EPS (Basic)	-93.78	-80.48	-85.84
EPS (Diluted)	-93.78	-80.48	-85.84
Free Cash Flow	-	-892	-474
Free Cash Flow Per Share	-	-111.47	-64.38
Gross Margin	76.69%	96.00%	43.48%
Operating Margin	-223.60%	-337.14%	-2556.52%
Profit Margin	-214.89%	-368.00%	-2747.83%
Free Cash Flow Margin	-	-509.71%	-2060.87%
EBITDA	-715.5	-514	-518
EBITDA Margin	-200.98%	-293.71%	-
D&A For EBITDA	80.5	76	70
EBIT	-796	-590	-588

Source: S&P Global Market Intelligence. Standard template. Financial Sources.